• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Ashley Addiction Treatment acquires Washington, DC area outpatient provider, Aquila Recovery

Share:

March 25, 2019

Ashley Addiction Treatment, one of the nation’s most respected names in the substance use disorder treatment industry, assumed active asset management of Aquila Recovery, an outpatient addiction treatment provider with locations in Chevy Chase, MD, Washington, DC, Leesburg, VA, and Herndon, VA. Through this acquisition, Ashley fulfills its longstanding plan to grow its presence in the Greater DC and Northern Virginia markets to create more access points for care to individuals and families impacted by this region’s alcohol and drug epidemic. Aquila will become a member of the Ashley system of care by July 1, 2019. In the interim, both organizations will retain their respective names and will work diligently to integrate and provide a more comprehensive continuum of care.

Founded in 2011, Aquila has operated as one of the premier DC area outpatient providers and offered a similarly high standard of care to Ashley. Aquila founder and celebrated recovery advocate, Johnny Allem, said, “We recognize the tremendous opportunity that awaits us. I know that Aquila is in good hands and I have full confidence in Ashley’s ability to sustain and grow what we’ve built here.”

“We have always had a profound appreciation for Aquila’s care model, and by combining our staff and resources, we can now offer our patients and families more comprehensive care and achieve greater success in supporting them on their recovery journeys,” said Ashley President & CEO, Rebecca Flood.

“This acquisition links our continuum of treatment services and ensures greater accessibility for people throughout the Greater DC and Northern Virginia region,” said Ashley Board Chairman, Jim Denvir.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

When the organizations officially join, Rebecca Flood will serve as President & CEO and oversee all operations.

Date: March 25, 2019

Source: MarketWatch

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • SeqOne Genomics Closes €20M Series a Round to Accelerate Genomic Medicine Platform RolloutSeqOne Genomics Closes €20M Series a Round to Accelerate Genomic Medicine Platform Rollout
  • Therapix Biosciences Provides Update on Planned Merger with Destiny Biosciences Global Corp.Therapix Biosciences Provides Update on Planned Merger with Destiny Biosciences Global Corp.
  • Canada Taps BlackBerry, Shopify to Help It Develop COVID-19 Contact Tracing AppsCanada Taps BlackBerry, Shopify to Help It Develop COVID-19 Contact Tracing Apps
  • Alfasigma Acquires the Entire Share Capital of Sofar, An Italian Pharmaceutical CompanyAlfasigma Acquires the Entire Share Capital of Sofar, An Italian Pharmaceutical Company
  • Photovoltaic Modules Market PESTEL Analysis, SWOT Analysis, CAGR and Value Chain Study to 2028Photovoltaic Modules Market PESTEL Analysis, SWOT Analysis, CAGR and Value Chain Study to 2028
  • Premier Health Provides Corporate UpdatePremier Health Provides Corporate Update
  • COVID-19’s Effect on Biopharma M&As in 2020COVID-19’s Effect on Biopharma M&As in 2020
  • Perrigo Completes Acquisition Of Ranir, Raises GuidancePerrigo Completes Acquisition Of Ranir, Raises Guidance

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications